Fosun Pharma To Participate In Consolidated Listing Of Small Pharmaceutical Firms
This article was originally published in PharmAsia News
Executive Summary
Small- and mid-sized pharmaceutical enterprises in China are facing especially tough times due to bottlenecks such as brand building and fund shortages. A group of small and medium firms in Beijing has announced its intention last April to band together and negotiate to bring investments public. Fosun Pharma has expressed interest and is having preliminary contact with the companies. If successful, the partnership will become a new model for China's pharmaceutical development. However, industry analysts observe that establishing such a venture comes with major challenges like the evaluation of each party's assets and securing government support. To address these issues, Beijing Pharmaceutical Profession Association will hold a meeting with 10 Beijing pharmaceutical enterprises to discuss the collaboration. (Click here for more - Chinese Language)